SCHEMBL2918641

SCHEMBL2918641

CCOC(C)OCCCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.48
LMNA P02545 2/20 0.43
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
CHRM2 P08172 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
CHRM1 P11229 1/20 0.42
DRD1 P21728 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRM1 P35372 1/20 0.42
DRD3 P35462 1/20 0.42
KCNH2 Q12809 1/20 0.42
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
SIGMAR1 Q99720 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL585803 0.89 LMNA (0.46) IDO1LMNASIGMAR1
SCHEMBL449609 0.87 LMNA (0.52) LMNASLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL682844 0.84 IDO1 (0.50) IDO1LMNASLC6A2SLC6A4SLC6A3
SCHEMBL2286309 0.83 PTGES (0.36) IDO1LMNAPPARGSIGMAR1
SCHEMBL3506182 0.82 MEN1 (0.44) IDO1KCNH2PPARGSIGMAR1
SCHEMBL12530260 0.81 IDO1 (0.55) IDO1LMNASLC6A2SLC6A4SLC6A3
SCHEMBL14865517 0.81 TSHR (0.43) IDO1LMNAPPARGPPARA
SCHEMBL4449191 0.81 CA1 (0.44) IDO1SLC6A2SLC6A4SLC6A3SIGMAR1
SCHEMBL22891047 0.80 IDO1 (0.50) IDO1LMNASLC6A2SLC6A4SLC6A3
SCHEMBL683437 0.79 L3MBTL1 (0.50) IDO1SLC6A2SLC6A4SLC6A3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025110206-A1 PERFUME, PERFUME COMPOSITION, METHOD FOR PRODUCING PERFUME, AND COMPOUND 三菱瓦斯化学株式会社 2025-05-30 WO disclosed
WO-2025104976-A1 FRAGRANCE COMPOSITION 花王株式会社 2025-05-22 WO disclosed
WO-2025104977-A1 NOVEL ALDEHYDE COMPOUND 花王株式会社 2025-05-22 WO disclosed
WO-2025004871-A1 PERFUME COMPOSITION 三菱瓦斯化学株式会社 2025-01-02 WO disclosed
WO-2024204512-A1 FUNCTIONAL PARTICLE DISPERSION 三菱鉛筆株式会社 2024-10-03 WO disclosed
WO-2023243499-A1 ALDEHYDE COMPOSITION 三菱瓦斯化学株式会社 2023-12-21 WO disclosed
EP-3514221-B1 USE AS A PERFUME MATERIAL MITSUBISHI GAS CHEMICAL CO (JP) 2022-01-19 EP disclosed
US-20200283696-A1 PERFUME COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-09-10 US disclosed
WO-2020012806-A1 CARBOXYLIC ESTER COMPOUND, PRODUCTION METHOD THEREFOR, COMPOSITION, AND PERFUME COMPOSITION 三菱瓦斯化学株式会社 2020-01-16 WO disclosed
US-20190241833-A1 PERFUME COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-08-08 US disclosed
CN-103282287-A Package KAO CORP 2013-09-04 CN disclosed
EP-1555261-B1 VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION KAO CORP (JP) 2010-09-01 EP disclosed
US-7786331-B2 Fragrance composition KAO CORPORATION (JP) 2010-08-31 US disclosed
US-7648956-B2 Fragrance composition KAO CORPORATION (JP) 2010-01-19 US disclosed
US-20100010275-A1 FRAGRANCE COMPOSITION KAO CORPORATION (JP) 2010-01-14 US disclosed
US-20090075859-A1 FRAGRANCE COMPOSITION KAO CORPORATION (JP) 2009-03-19 US disclosed
US-7491833-B2 Valerolactone compounds and perfume composition KAO CORPORATION (JP) 2009-02-17 US disclosed
EP-1897932-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2008-03-12 EP disclosed
US-20060258559-A1 Valerolactone compounds and perfume composition KAO CORPORATION (JP) 2006-11-16 US disclosed
EP-1555261-A1 VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION Kao Corporation (JP) 2005-07-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190241833-A1 PERFUME COMPOSITION H1-0, H1-2, CUTA IDO1 1600/4885LMNA 2621/4885SLC6A2 4177/4885
US-20090075859-A1 FRAGRANCE COMPOSITION FAAH, NAT1, NAA40 IDO1 1038/4885LMNA 3359/4885SLC6A2 4661/4885
US-20200283696-A1 PERFUME COMPOSITION H1-0, H1-2, CUTA IDO1 1600/4885LMNA 2621/4885SLC6A2 4177/4885
US-20100010275-A1 FRAGRANCE COMPOSITION FAAH, NAT1, NAA40 IDO1 1038/4885LMNA 3359/4885SLC6A2 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.